7T T2*-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease

Neurobiology of Aging

Volumn 36, Issue 1, 2015, Pages 20-26

  van Rooden, Sanneke ^a   Doan, Nhat Trung ^a   Versluis, Maarten J ^a   Goos, Jeroen D C ^b   Webb, Andrew G ^a   Oleksik, Ania M ^a   van der Flier, Wiesje M ^b,c   Scheltens, Philip ^b   Barkhof, Frederik ^c   Weverling Rynsburger, Annelies W E ^d   Blauw, Gerard Jan ^a,e   Reiber, Johan H C ^a   van Buchem, Mark A ^a   Milles, Julien ^a   van der Grond, Jeroen ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Diaconessen Hospital   (Netherlands)

^e MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

AD pathology; Alzheimer's disease; Brain imaging; Early onset AD; Human 7T MRI; Phase

Indexed keywords

IRON; AMYLOID BETA PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; EXPLORATORY RESEARCH; FEMALE; HUMAN; IMAGE PROCESSING; INFERIOR PARIETAL GYRUS; IRON STORAGE; MALE; MIDDLE CINGULATE GYRUS; MIDDLE FRONTAL GYRUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ONSET AGE; POSTCENTRAL GYRUS; PRECUNEUS; SUPERIOR PARIETAL GYRUS; COMPARATIVE STUDY; DIFFUSION WEIGHTED IMAGING; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CEREBRAL CORTEX; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84920602939     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.07.006     Document Type: Article

References (54)

1. Balasa M., Gelpi E., Antonell A., Rey M.J., Sanchez-Valle R., Molinuevo J.L., Llado A. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease. Neurology 2011, 76:1720-1725.
2. Bigio E.H., Hynan L.S., Sontag E., Satumtira S., White C.L. Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis. Neuropathol. Appl. Neurobiol. 2002, 28:218-227.
3. Canu E., Frisoni G.B., Agosta F., Pievani M., Bonetti M., Filippi M. Early and late onset Alzheimer's disease patients have distinct patterns of white matter damage. Neurobiol. Aging 2012, 33:1023-1033.
4. Cho H., Jeon S., Kang S.J., Lee J.M., Lee J.H., Kim G.H., Shin J.S., Kim C.H., Noh Y., Im K., Kim S.T., Chin J., Seo S.W., Na D.L. Longitudinal changes of cortical thickness in early- versus late-onset Alzheimer's disease. Neurobiol. Aging 2013, 34:1921.
5. Choo I.H., Lee D.Y., Kim J.W., Seo E.H., Lee D.S., Kim Y.K., Kim S.G., Park S.Y., Woo J.I., Yoon E.J. Relationship of amyloid-beta burden with age-at-onset in Alzheimer disease. Am. J. Geriatr. Psychiatry 2011, 19:627-634.
6. Collins D.L., Neelin P., Peters T.M., Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J.Comput. Assist. Tomogr. 1994, 18:192-205.
7. Doan N.T., van Rooden S., Versluis M.J., Webb A.G., van der Grond J., van Buchem M.A., Reiber J.H., Milles J. Combined magnitude and phase-based segmentation of the cerebral cortex in 7T MR images of the elderly. J.Magn. Reson. Imaging 2012, 36:99-109.
8. Duce J.A., Tsatsanis A., Cater M.A., James S.A., Robb E., Wikhe K., Leong S.L., Perez K., Johanssen T., Greenough M.A., Cho H.H., Galatis D., Moir R.D., Masters C.L., McLean C., Tanzi R.E., Cappai R., Barnham K.J., Ciccotosto G.D., Rogers J.T., Bush A.I. Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 2010, 142:857-867.
9. Duyn J.H. Study of brain anatomy with high-field MRI: recent progress. Magn. Reson. Imaging 2010, 28:1210-1215.
10. Duyn J.H., van Gelderen P., Li T.Q., de Zwart J.A., Koretsky A.P., Fukunaga M. High-field MRI of brain cortical substructure based on signal phase. Proc. Natl. Acad. Sci. U.S.A 2007, 104:11796-11801.
11. Exley C. Aluminium and iron, but neither copper nor zinc, are key to the precipitation of beta-sheets of Abeta_{42} in senile plaque cores in Alzheimer's disease. J.Alzheimers Dis. 2006, 10:173-177.
12. Fornari E., Maeder P., Meuli R., Ghika J., Knyazeva M.G. Demyelination of superficial white matter in early Alzheimer's disease: a magnetization transfer imaging study. Neurobiol. Aging 2012, 33:428-519.
13. Frisoni G.B., Pievani M., Testa C., Sabattoli F., Bresciani L., Bonetti M., Beltramello A., Hayashi K.M., Toga A.W., Thompson P.M. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain 2007, 130:720-730.
14. Grundke-Iqbal I., Fleming J., Tung Y.C., Lassmann H., Iqbal K., Joshi J.G. Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol. 1990, 81:105-110.
15. Haacke E.M., Xu Y., Cheng Y.C., Reichenbach J.R. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 2004, 52:612-618.
16. Haacke E.M., Ayaz M., Khan A., Manova E.S., Krishnamurthy B., Gollapalli L., Ciulla C., Kim I., Petersen F., Kirsch W. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J.Magn. Reson. Imaging 2007, 26:256-264.
17. Hallgren B., Sourander P. The effect of age on the non-haemin iron in the human brain. J.Neurochem. 1958, 3:41-51.
18. Ho G.J., Hansen L.A., Alford M.F., Foster K., Salmon D.P., Galasko D., Thal L.J., Masliah E. Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease. Neuroreport 2002, 13:1825-1828.
19. Igarashi H., Tsujita M., Suzuki Y., Kwee I.L., Nakada T. Inhibition of aquaporin-4 significantly increases regional cerebral blood flow. Neuroreport 2013, 24:324-328.
20. Igarashi H., Tsujita M., Kwee I.L., Nakada T. Water influx into cerebrospinal fluid is primarily controlled by aquaporin-4, not by aquaporin-1: 17O JJVCPE MRI study in knockout mice. Neuroreport 2014, 25:39-43.
21. Iliff J.J., Wang M., Liao Y., Plogg B.A., Peng W., Gundersen G.A., Benveniste H., Vates G.E., Deane R., Goldman S.A., Nagelhus E.A., Nedergaard M. Aparavascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci. Transl. Med. 2012, 4:147ra111.
22. Imamura T., Takatsuki Y., Fujimori M., Hirono N., Ikejiri Y., Shimomura T., Hashimoto M., Yamashita H., Mori E. Age at onset and language disturbances in Alzheimer's disease. Neuropsychologia 1998, 36:945-949.
23. Ishii K., Kawachi T., Sasaki H., Kono A.K., Fukuda T., Kojima Y., Mori E. Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. AJNR Am. J. Neuroradiol. 2005, 26:333-340.
24. Jacobs D., Sano M., Marder K., Bell K., Bylsma F., Lafleche G., Albert M., Brandt J., Stern Y. Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology 1994, 44:1215-1220.
25. Kaiser N.C., Melrose R.J., Liu C., Sultzer D.L., Jimenez E., Su M., Monserratt L., Mendez M.F. Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen. 2012, 27:520-529.
26. Karas G., Scheltens P., Rombouts S., van S.R., Klein M., Jones B., vanderFlier W., Vrenken H., Barkhof F. Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology 2007, 49:967-976.
27. Kim E.J., Cho S.S., Jeong Y., Park K.C., Kang S.J., Kang E., Kim S.E., Lee K.H., Na D.L. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain 2005, 128:1790-1801.
28. Kitaura H., Tsujita M., Huber V.J., Kakita A., Shibuki K., Sakimura K., Kwee I.L., Nakada T. Activity-dependent glial swelling is impaired in aquaporin-4 knockout mice. Neurosci. Res. 2009, 64:208-212.
29. Klein S., Staring M., Murphy K., Viergever M.A., Pluim J.P. Elastix: a toolbox for intensity-based medical image registration. IEEE Trans. Med. Imaging 2010, 29:196-205.
30. Koedam E.L., Lauffer V., van der Vlies A.E., van der Flier W.M., Scheltens P., Pijnenburg Y.A. Early-versus late-onset Alzheimer's disease: more than age alone. J.Alzheimers Dis. 2010, 19:1401-1408.
31. Koss E., Edland S., Fillenbaum G., Mohs R., Clark C., Galasko D., Morris J.C. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: a CERAD analysis, Part XII. Neurology 1996, 46:136-141.
32. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J.Neurol. Sci. 1998, 158:47-52.
33. Lynoe N., Sandlund M., Dahlqvist G., Jacobsson L. Informed consent: study of quality of information given to participants in a clinical trial. BMJ 1991, 303:610-613.
34. Marshall G.A., Fairbanks L.A., Tekin S., Vinters H.V., Cummings J.L. Early-onset Alzheimer's disease is associated with greater pathologic burden. J.Geriatr. Psychiatry Neurol. 2007, 20:29-33.
35. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
36. Meadowcroft M.D., Connor J.R., Smith M.B., Yang Q.X. MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J.Magn. Reson. Imaging 2009, 29:997-1007.
37. Minati L., Edginton T., Bruzzone M.G., Giaccone G. Current concepts in Alzheimer's disease: a multidisciplinary review. Am. J. Alzheimers Dis. Other Demen. 2009, 24:95-121.
38. Moller C., Vrenken H., Jiskoot L., Versteeg A., Barkhof F., Scheltens P., vanderFlier W.M. Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease. Neurobiol. Aging 2013, 34:2014-2022.
39. Nakada T., Matsuzawa H., Igarashi H., Fujii Y., Kwee I.L. Invivo visualization of senile-plaque-like pathology in Alzheimer's disease patients by MR microscopy on a 7T system. J.Neuroimaging 2008, 18:125-129.
40. Nakada T., Matsuzawa H., Igarashi H., Kwee I.L. Expansion of corticomedullary junction high-susceptibility region (CMJ-HSR) with aging: a clue in the pathogenesis of Alzheimer's disease?. J.Neuroimaging 2012, 22:379-383.
41. Ogg R.J., Langston J.W., Haacke E.M., Steen R.G., Taylor J.S. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn. Reson. Imaging 1999, 17:1141-1148.
42. Ossenkoppele R., Zwan M.D., Tolboom N., van Assema D.M., Adriaanse S.F., Kloet R.W., Boellaard R., Windhorst A.D., Barkhof F., Lammertsma A.A., Scheltens P., vanderFlier W.M., vanBerckel B.N. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Brain 2012, 135:2115-2125.
43. Rabinovici G.D., Furst A.J., Alkalay A., Racine C.A., O'Neil J.P., Janabi M., Baker S.L., Agarwal N., Bonasera S.J., Mormino E.C., Weiner M.W., Gorno-Tempini M.L., Rosen H.J., Miller B.L., Jagust W.J. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 2010, 133:512-528.
44. Sa F., Pinto P., Cunha C., Lemos R., Letra L., Simoes M., Santana I. Differences between early and late-onset Alzheimer's disease in neuropsychological tests. Front. Neurol. 2012, 3:81.
45. Sakamoto S., Ishii K., Sasaki M., Hosaka K., Mori T., Matsui M., Hirono N., Mori E. Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease. J.Neurol. Sci. 2002, 200:27-32.
46. Schar M., Kozerke S., Fischer S.E., Boesiger P. Cardiac SSFP imaging at 3 Tesla. Magn. Reson. Med. 2004, 51:799-806.
47. Smits L.L., Pijnenburg Y.A., Koedam E.L., van der Vlies A.E., Reuling I.E., Koene T., Teunissen C.E., Scheltens P., vanderFlier W.M. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile. J.Alzheimers Dis. 2012, 30:101-108.
48. Svennerholm L., Gottfries C.G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J.Neurochem. 1994, 62:1039-1047.
49. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
50. van der Vlies A.E., Koedam E.L., Pijnenburg Y.A., Twisk J.W., Scheltens P., van der Flier W.M. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset. Psychol. Med. 2009, 39:1907-1911.
51. van Rooden S., Maat-Schieman M.L., Nabuurs R.J., van der Weerd L., van Duijn S., van Duinen S.G., Natte R., vanBuchem M.A., vanderGrond J. Cerebral amyloidosis: postmortem detection with human 7.0-T MR imaging system. Radiology 2009, 253:788-796.
52. van Rooden S., Versluis M.J., Liem M.K., Milles J., Maier A.B., Oleksik A.M., Webb A.G., vanBuchem M.A., vanderGrond J. Cortical phase changes in Alzheimer's disease at 7T MRI: a novel imaging marker. Alzheimers Dement 2014, 10:e19-e26.
53. Versluis M.J., Peeters J.M., van Rooden S., van der Grond J., van Buchem M.A., Webb A.G., vanOsch M.J. Origin and reduction of motion and f0 artifacts in high resolution T2*-weighted magnetic resonance imaging: application in Alzheimer's disease patients. Neuroimage 2010, 51:1082-1088.
54. Yao B., Li T.Q., van Gelderen P., Shmueli K., de Zwart J.A., Duyn J.H. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 2009, 44:1259-1266.